Intervention
Brain MRI
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
13 shownStudy of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183ANCT06932809 · 2025-05-09
RECRUITINGEvaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Early Treatment Using an Automated Delivery System in Children With Type 1 DiabetesNCT06461065 · 2025-02-20
RECRUITINGStudy of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503NCT06303921 · 2024-02-16
RECRUITINGMotor Slowing and Its Lesion-related Correlates in Alzheimer's DiseaseNCT02811653 · 2015-12-16
RECRUITINGAssessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS PatientsNCT04860947 · 2019-06-25
UNKNOWNInnovative Biomarkers in de Novo Parkinson's DiseaseNCT03940677 · 2019-04-25
TERMINATEDEvaluation of Cerebral Small Vessel Disease in Patient With Primary AldosteronismNCT03821571 · 2019-01-25
UNKNOWNBrain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerNCT03617341 · 2018-10-02
UNKNOWNRisk Factors in Early Multiple SclerosisNCT03586986 · 2018-07-26
UNKNOWNBENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up StudiesNCT03269175 · 2017-09-29
COMPLETEDCOPD-Related Physiology and the BrainNCT03269721 · 2017-05-01
COMPLETEDRotating Frame Relaxation Imaging in Patients With Multiple SclerosisNCT02403570 · 2015-02-01
COMPLETEDExploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsNCT04474405 · 2013-08-16
COMPLETEDCommon conditions
Multiple Sclerosis4Alzheimer Disease2Tauopathies2Biomarkers1Clinically Isolated Syndrome1Cognitive Impairment1Diabetes1Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism1Healthy Controls Group - Age and Sex-matched1Magnetic Resonance Imaging1Metastatic Breast Cancer With HER2 Positive1Multiple Sclerosis, Chronic Progressive1Multiple Sclerosis, Relapsing-Remitting1Parkinson's Disease1Pulmonary Disease, Chronic Obstructive (COPD)1Radiologically Isolated Syndrome1Triple Negative Breast Cancer1
Leading sponsors
University of Pennsylvania
2
Assistance Publique - Hôpitaux de Paris
1
Avid Radiopharmaceuticals
1
Bayer
1
Centre Hospitalier Universitaire de Nīmes
1
Centre Hospitalier Universitaire, Amiens
1
Karin Hoth
1
National Taiwan University Hospital
1
Turku University Hospital
1
University Hospital, Grenoble
1
University of Colorado, Denver
1
Yonsei University
1
Trial status mix
COMPLETED4
RECRUITING4
UNKNOWN4
TERMINATED1
Phase mix
EARLY_PHASE13
NA3
PHASE11
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.